- From @MichiganRadio: Prescription drug costs are rising, but Rep. Kildee wants to change that ow.ly/nmnU30qbOsQ 4 hours ago
- Religious Coercion of Physicians: Whose Conscience Is It Anyway? msubioethics.com/2020/01/23/rel… #BioethicsInTheNews https://t.co/aYzqSWCCzN 23 hours ago
- The College of Human Medicine is hiring for the position of Director of the Center for Ethics and Humanities in the… twitter.com/i/web/status/1… 1 day ago
- "Day in and day out, I cared for patients with cancer, a disease that had become familiar in a professional sense f… twitter.com/i/web/status/1… 1 day ago
- What happens when a patient with terminal cancer requests aid-in-dying in a Catholic hospital system? Dr. Leonard F… twitter.com/i/web/status/1… 1 day ago
Top Posts & Pages
- Religious Coercion of Physicians: Whose Conscience Is It Anyway?
- Gene Editing: God’s Will or God’s Won’t
- Recognizing Menstrual Supplies as Basic Health Necessities: The Bioethics of #FreePeriods
- “Ask your doctor” – or just check Instagram?
- Signed Off: Unconsented-To Cesarean Section, A Quarter Century After A.C.
Tag Archives: pharmaceutical industry
This post is a part of our Bioethics in the News series By Arthur Ward, PhD Just weeks ago, the U.S. Food and Drug Administration approved Ketamine as the first new drug in decades for treatment of depression. Or rather, while the … Continue reading
This post is a part of our Bioethics in the News series By Devan Stahl, PhD When I was in my mid-twenties I went to my physician to have a mole on my face removed. Before my dermatologist began the procedure, however, … Continue reading
This post is a part of our Bioethics in the News series By Jennifer Carter-Johnson, PhD, JD A recent New York Times article described the problems that patients are having gaining access to a new class of cholesterol reducers, called PCSK9 … Continue reading
Center Assistant Professor Dr. Laura Cabrera and co-authors Hayden M. K. Boyce, MD, Rachel McKenzie, and Robyn Bluhm, PhD, have an article in the August 2018 issue of Neurosurgical Focus. “Conflicts of interest and industry professional relationships in psychiatric neurosurgery: a … Continue reading
This post is a part of our Bioethics in the News series By Leonard M. Fleck, PhD Some recent headlines worth noting: “U.S. Prescription Drug Costs Are a Crime,” “Americans Say They are Suffering as Drug Costs Continue to Rise,” “When … Continue reading
Center Professor Dr. Len Fleck presented at the 20th Annual Michigan State Medical Society Conference on Bioethics, held on November 12, 2016 in Ann Arbor. The theme of the conference was “Ethical Issues in the Pharmaceutical Industry: Current Controversies and … Continue reading